Global Epilepsy Diagnosis & Treatment Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Epilepsy Diagnosis & Treatment estimated at US$ 9065.6 million in the year 2022, is projected to reach a revised size of US$ 21010 million by 2028, growing at a CAGR of 15.0% during the forecast period 2022-2028.

Increasing prevalence of epilepsy is a major driver for the market. According to a report by the World Health Organization (2018), about 50 million people across the world are estimated to suffer from epilepsy, making it one of the most common neurological diseases. In addition, the report states that the total number of people aged 65 or more is projected to increase from 524 million in 2010 to approximately 1.5 billion by 2050.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Epilepsy Diagnosis & Treatment companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Epilepsy Diagnosis & Treatment market. Further, it explains the major drivers and regional dynamics of the global Epilepsy Diagnosis & Treatment market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Pfizer

Johnson & Johnson

UCB Pharma

Abbott

GlaxoSmithKline

Novartis

Sanofi

Takeda

Medtronic

Natus Medical

Siemens

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Diagnosis (Neurological Exam, Blood Test, Imaging)

Treatment (Medication, Surgery)

Hospitals

Clinics

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Epilepsy Diagnosis & Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Epilepsy Diagnosis & Treatment market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Epilepsy Diagnosis & Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Epilepsy Diagnosis & Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Epilepsy Diagnosis & Treatment revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Epilepsy Diagnosis & Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Epilepsy Diagnosis & Treatment revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Pfizer, Johnson & Johnson, UCB Pharma, Abbott, GlaxoSmithKline, Novartis, Sanofi, Takeda and Medtronic, etc.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Epilepsy Diagnosis & Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Diagnosis (Neurological Exam, Blood Test, Imaging)

1.2.3 Treatment (Medication, Surgery)

1.3 Market by Application

1.3.1 Global Epilepsy Diagnosis & Treatment Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Clinics

1.4 Study Objectives

1.5 Years Considered

2.1 Global Epilepsy Diagnosis & Treatment Market Size (2017-2028)

2.2 Epilepsy Diagnosis & Treatment Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Epilepsy Diagnosis & Treatment Market Size by Region (2017-2022)

2.4 Global Epilepsy Diagnosis & Treatment Market Size Forecast by Region (2023-2028)

2.5 Global Top Epilepsy Diagnosis & Treatment Countries Ranking by Market Size

3.1 Global Epilepsy Diagnosis & Treatment Revenue by Players

3.1.1 Global Epilepsy Diagnosis & Treatment Revenue by Players (2017-2022)

3.1.2 Global Epilepsy Diagnosis & Treatment Market Share by Players (2017-2022)

3.2 Global Epilepsy Diagnosis & Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Epilepsy Diagnosis & Treatment Revenue

3.4 Global Epilepsy Diagnosis & Treatment Market Concentration Ratio

3.4.1 Global Epilepsy Diagnosis & Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Diagnosis & Treatment Revenue in 2021

3.5 Global Epilepsy Diagnosis & Treatment Key Players Head office and Area Served

3.6 Key Players Epilepsy Diagnosis & Treatment Product Solution and Service

3.7 Date of Enter into Epilepsy Diagnosis & Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Epilepsy Diagnosis & Treatment Historic Revenue by Type (2017-2022)

4.2 Global Epilepsy Diagnosis & Treatment Forecasted Revenue by Type (2023-2028)

5.1 Global Epilepsy Diagnosis & Treatment Historic Market Size by Application (2017-2022)

5.2 Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Application (2023-2028)

6.1 North America Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022)

6.2 North America Epilepsy Diagnosis & Treatment Revenue by Type (2017-2028)

6.3 North America Epilepsy Diagnosis & Treatment Revenue by Application (2017-2028)

6.4 North America Epilepsy Diagnosis & Treatment Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7.1 Europe Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022)

7.2 Europe Epilepsy Diagnosis & Treatment Revenue by Type (2017-2028)

7.3 Europe Epilepsy Diagnosis & Treatment Revenue by Application (2017-2028)

7.4 Europe Epilepsy Diagnosis & Treatment Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8.1 Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022)

8.2 Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Type (2017-2028)

8.3 Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Application (2017-2028)

8.4 Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9.1 Latin America Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022)

9.2 Latin America Epilepsy Diagnosis & Treatment Revenue by Type (2017-2028)

9.3 Latin America Epilepsy Diagnosis & Treatment Revenue by Application (2017-2028)

9.4 Latin America Epilepsy Diagnosis & Treatment Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10.1 Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022)

10.2 Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Type (2017-2028)

10.3 Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Application (2017-2028)

10.4 Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 U.A.E

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Epilepsy Diagnosis & Treatment Products and Services

11.1.4 Pfizer Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.1.5 Pfizer Epilepsy Diagnosis & Treatment SWOT Analysis

11.1.6 Pfizer Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Epilepsy Diagnosis & Treatment Products and Services

11.2.4 Johnson & Johnson Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.2.5 Johnson & Johnson Epilepsy Diagnosis & Treatment SWOT Analysis

11.2.6 Johnson & Johnson Recent Developments

11.3 UCB Pharma

11.3.1 UCB Pharma Company Details

11.3.2 UCB Pharma Business Overview

11.3.3 UCB Pharma Epilepsy Diagnosis & Treatment Products and Services

11.3.4 UCB Pharma Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.3.5 UCB Pharma Epilepsy Diagnosis & Treatment SWOT Analysis

11.3.6 UCB Pharma Recent Developments

11.4 Abbott

11.4.1 Abbott Company Details

11.4.2 Abbott Business Overview

11.4.3 Abbott Epilepsy Diagnosis & Treatment Products and Services

11.4.4 Abbott Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.4.5 Abbott Epilepsy Diagnosis & Treatment SWOT Analysis

11.4.6 Abbott Recent Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Epilepsy Diagnosis & Treatment Products and Services

11.5.4 GlaxoSmithKline Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.5.5 GlaxoSmithKline Epilepsy Diagnosis & Treatment SWOT Analysis

11.5.6 GlaxoSmithKline Recent Developments

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Epilepsy Diagnosis & Treatment Products and Services

11.6.4 Novartis Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.6.5 Novartis Epilepsy Diagnosis & Treatment SWOT Analysis

11.6.6 Novartis Recent Developments

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Epilepsy Diagnosis & Treatment Products and Services

11.7.4 Sanofi Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.7.5 Sanofi Epilepsy Diagnosis & Treatment SWOT Analysis

11.7.6 Sanofi Recent Developments

11.8 Takeda

11.8.1 Takeda Company Details

11.8.2 Takeda Business Overview

11.8.3 Takeda Epilepsy Diagnosis & Treatment Products and Services

11.8.4 Takeda Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.8.5 Takeda Epilepsy Diagnosis & Treatment SWOT Analysis

11.8.6 Takeda Recent Developments

11.9 Medtronic

11.9.1 Medtronic Company Details

11.9.2 Medtronic Business Overview

11.9.3 Medtronic Epilepsy Diagnosis & Treatment Products and Services

11.9.4 Medtronic Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.9.5 Medtronic Epilepsy Diagnosis & Treatment SWOT Analysis

11.9.6 Medtronic Recent Developments

11.10 Natus Medical

11.10.1 Natus Medical Company Details

11.10.2 Natus Medical Business Overview

11.10.3 Natus Medical Epilepsy Diagnosis & Treatment Products and Services

11.10.4 Natus Medical Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.10.5 Natus Medical Epilepsy Diagnosis & Treatment SWOT Analysis

11.10.6 Natus Medical Recent Developments

11.11 Siemens

11.11.1 Siemens Company Details

11.11.2 Siemens Business Overview

11.11.3 Siemens Epilepsy Diagnosis & Treatment Products and Services

11.11.4 Siemens Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022)

11.11.5 Siemens Recent Developments

12.1 Epilepsy Diagnosis & Treatment Market Trends

12.2 Epilepsy Diagnosis & Treatment Market Drivers

12.3 Epilepsy Diagnosis & Treatment Market Challenges

12.4 Epilepsy Diagnosis & Treatment Market Restraints

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

List of Tables

    Table 1. Global Epilepsy Diagnosis & Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Diagnosis (Neurological Exam, Blood Test, Imaging)

    Table 3. Key Players of Treatment (Medication, Surgery)

    Table 4. Global Epilepsy Diagnosis & Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 5. Global Epilepsy Diagnosis & Treatment Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

    Table 6. Global Epilepsy Diagnosis & Treatment Revenue by Region (2017-2022) & (US$ Million)

    Table 7. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Region (2017-2022)

    Table 8. Global Epilepsy Diagnosis & Treatment Revenue by Players (2017-2022) & (US$ Million)

    Table 9. Global Epilepsy Diagnosis & Treatment Market Share by Players (2017-2022)

    Table 10. Global Top Epilepsy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Diagnosis & Treatment as of 2021)

    Table 11. Ranking of Global Top Epilepsy Diagnosis & Treatment Companies by Revenue (US$ Million) in 2021

    Table 12. Global 5 Largest Players Market Share by Epilepsy Diagnosis & Treatment Revenue (CR5 and HHI) & (2017-2022)

    Table 13. Key Players Headquarters and Area Served

    Table 14. Key Players Epilepsy Diagnosis & Treatment Product Solution and Service

    Table 15. Date of Key Manufacturers Enter into Epilepsy Diagnosis & Treatment Market

    Table 16. Mergers & Acquisitions, Expansion Plans

    Table 17. Global Epilepsy Diagnosis & Treatment Market Size by Type (2017-2022) & (US$ Million)

    Table 18. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2017-2022)

    Table 19. Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 20. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2023-2028)

    Table 21. Global Epilepsy Diagnosis & Treatment Market Size by Application (2017-2022) & (US$ Million)

    Table 22. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Application (2017-2022)

    Table 23. Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 24. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Application (2023-2028)

    Table 25. North America Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022) & (US$ Million)

    Table 26. North America Epilepsy Diagnosis & Treatment Revenue by Type (2017-2022) & (US$ Million)

    Table 27. North America Epilepsy Diagnosis & Treatment Revenue by Type (2023-2028) & (US$ Million)

    Table 28. North America Epilepsy Diagnosis & Treatment Revenue by Application (2017-2022) & (US$ Million)

    Table 29. North America Epilepsy Diagnosis & Treatment Revenue by Application (2023-2028) & (US$ Million)

    Table 30. North America Epilepsy Diagnosis & Treatment Revenue by Country (2017-2022) & (US$ Million)

    Table 31. North America Epilepsy Diagnosis & Treatment Revenue by Country (2023-2028) & (US$ Million)

    Table 32. Europe Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022) & (US$ Million)

    Table 33. Europe Epilepsy Diagnosis & Treatment Revenue by Type (2017-2022) & (US$ Million)

    Table 34. Europe Epilepsy Diagnosis & Treatment Revenue by Type (2023-2028) & (US$ Million)

    Table 35. Europe Epilepsy Diagnosis & Treatment Revenue by Application (2017-2022) & (US$ Million)

    Table 36. Europe Epilepsy Diagnosis & Treatment Revenue by Application (2023-2028) & (US$ Million)

    Table 37. Europe Epilepsy Diagnosis & Treatment Revenue by Country (2017-2022) & (US$ Million)

    Table 38. Europe Epilepsy Diagnosis & Treatment Revenue by Country (2023-2028) & (US$ Million)

    Table 39. Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022) & (US$ Million)

    Table 40. Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Type (2017-2022) & (US$ Million)

    Table 41. Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Type (2023-2028) & (US$ Million)

    Table 42. Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Application (2017-2022) & (US$ Million)

    Table 43. Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Application (2023-2028) & (US$ Million)

    Table 44. Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Region (2017-2022) & (US$ Million)

    Table 45. Asia Pacific Epilepsy Diagnosis & Treatment Revenue by Region (2023-2028) & (US$ Million)

    Table 46. Latin America Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022) & (US$ Million)

    Table 47. Latin America Epilepsy Diagnosis & Treatment Revenue by Type (2017-2022) & (US$ Million)

    Table 48. Latin America Epilepsy Diagnosis & Treatment Revenue by Type (2023-2028) & (US$ Million)

    Table 49. Latin America Epilepsy Diagnosis & Treatment Revenue by Application (2017-2022) & (US$ Million)

    Table 50. Latin America Epilepsy Diagnosis & Treatment Revenue by Application (2023-2028) & (US$ Million)

    Table 51. Latin America Epilepsy Diagnosis & Treatment Revenue by Country (2017-2022) & (US$ Million)

    Table 52. Latin America Epilepsy Diagnosis & Treatment Revenue by Country (2023-2028) & (US$ Million)

    Table 53. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Company (2020-2022) & (US$ Million)

    Table 54. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Type (2017-2022) & (US$ Million)

    Table 55. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Type (2023-2028) & (US$ Million)

    Table 56. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Application (2017-2022) & (US$ Million)

    Table 57. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Application (2023-2028) & (US$ Million)

    Table 58. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Country (2017-2022) & (US$ Million)

    Table 59. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue by Country (2023-2028) & (US$ Million)

    Table 60. Pfizer Company Details

    Table 61. Pfizer Business Overview

    Table 62. Pfizer Epilepsy Diagnosis & Treatment Product and Services

    Table 63. Pfizer Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 64. Pfizer Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 65. Pfizer Recent Developments

    Table 66. Johnson & Johnson Company Details

    Table 67. Johnson & Johnson Business Overview

    Table 68. Johnson & Johnson Epilepsy Diagnosis & Treatment Product and Services

    Table 69. Johnson & Johnson Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 70. Johnson & Johnson Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 71. Johnson & Johnson Recent Developments

    Table 72. UCB Pharma Company Details

    Table 73. UCB Pharma Business Overview

    Table 74. UCB Pharma Epilepsy Diagnosis & Treatment Product and Services

    Table 75. UCB Pharma Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 76. UCB Pharma Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 77. UCB Pharma Recent Developments

    Table 78. Abbott Company Details

    Table 79. Abbott Business Overview

    Table 80. Abbott Epilepsy Diagnosis & Treatment Product and Services

    Table 81. Abbott Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 82. Abbott Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 83. Abbott Recent Developments

    Table 84. GlaxoSmithKline Company Details

    Table 85. GlaxoSmithKline Business Overview

    Table 86. GlaxoSmithKline Epilepsy Diagnosis & Treatment Product and Services

    Table 87. GlaxoSmithKline Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 88. GlaxoSmithKline Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 89. GlaxoSmithKline Recent Developments

    Table 90. Novartis Company Details

    Table 91. Novartis Business Overview

    Table 92. Novartis Epilepsy Diagnosis & Treatment Product and Services

    Table 93. Novartis Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 94. Novartis Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 95. Novartis Recent Developments

    Table 96. Sanofi Company Details

    Table 97. Sanofi Business Overview

    Table 98. Sanofi Epilepsy Diagnosis & Treatment Product and Services

    Table 99. Sanofi Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 100. Sanofi Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 101. Sanofi Recent Developments

    Table 102. Takeda Company Details

    Table 103. Takeda Business Overview

    Table 104. Takeda Epilepsy Diagnosis & Treatment Product and Services

    Table 105. Takeda Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 106. Takeda Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 107. Takeda Recent Developments

    Table 108. Medtronic Company Details

    Table 109. Medtronic Business Overview

    Table 110. Medtronic Epilepsy Diagnosis & Treatment Product and Services

    Table 111. Medtronic Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 112. Medtronic Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 113. Medtronic Recent Developments

    Table 114. Natus Medical Company Details

    Table 115. Natus Medical Business Overview

    Table 116. Natus Medical Epilepsy Diagnosis & Treatment Product and Services

    Table 117. Natus Medical Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 118. Natus Medical Epilepsy Diagnosis & Treatment SWOT Analysis

    Table 119. Natus Medical Recent Developments

    Table 120. Siemens Company Details

    Table 121. Siemens Business Overview

    Table 122. Siemens Epilepsy Diagnosis & Treatment Product and Services

    Table 123. Siemens Epilepsy Diagnosis & Treatment Revenue in Epilepsy Diagnosis & Treatment Business (2017-2022) & (US$ Million)

    Table 124. Siemens Recent Developments

    Table 125. Epilepsy Diagnosis & Treatment Market Trends

    Table 126. Epilepsy Diagnosis & Treatment Market Drivers

    Table 127. Epilepsy Diagnosis & Treatment Market Challenges

    Table 128. Epilepsy Diagnosis & Treatment Market Restraints

    Table 129. Research Programs/Design for This Report

    Table 130. Key Data Information from Secondary Sources

    Table 131. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Epilepsy Diagnosis & Treatment Sales Market Share by Type: 2021 VS 2028

    Figure 2. Diagnosis (Neurological Exam, Blood Test, Imaging) Features

    Figure 3. Treatment (Medication, Surgery) Features

    Figure 4. Global Epilepsy Diagnosis & Treatment Sales Market Share by Application: 2021 VS 2028

    Figure 5. Hospitals Case Studies

    Figure 6. Clinics Case Studies

    Figure 7. Epilepsy Diagnosis & Treatment Report Years Considered

    Figure 8. Global Epilepsy Diagnosis & Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 9. Global Epilepsy Diagnosis & Treatment Market Size 2017-2028 (US$ Million)

    Figure 10. Global Epilepsy Diagnosis & Treatment Market Size Market Share by Region: 2021 VS 2028

    Figure 11. Global Epilepsy Diagnosis & Treatment Revenue Market Share by Region in 2017 VS 2022

    Figure 12. Global Top 10 Epilepsy Diagnosis & Treatment Countries Ranking by Market Size (US$ Million) in 2021

    Figure 13. Global Epilepsy Diagnosis & Treatment Market Share by Players in 2021

    Figure 14. Global Top Epilepsy Diagnosis & Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Diagnosis & Treatment as of 2021)

    Figure 15. The Top 10 and 5 Players Market Share by Epilepsy Diagnosis & Treatment Revenue in 2021

    Figure 16. North America Epilepsy Diagnosis & Treatment Revenue Market Share by Company in 2021

    Figure 17. North America Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2017-2028)

    Figure 18. North America Epilepsy Diagnosis & Treatment Revenue Market Share by Application (2017-2028)

    Figure 19. North America Epilepsy Diagnosis & Treatment Revenue Share by Country (2017-2028)

    Figure 20. U.S. Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 21. Canada Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 22. Europe Epilepsy Diagnosis & Treatment Revenue Market Share by Company in 2021

    Figure 23. Europe Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2017-2028)

    Figure 24. Europe Epilepsy Diagnosis & Treatment Revenue Market Share by Application (2017-2028)

    Figure 25. Europe Epilepsy Diagnosis & Treatment Revenue Share by Country (2017-2028)

    Figure 26. Germany Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 27. France Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 28. U.K. Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 29. Italy Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 30. Russia Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 31. Asia Pacific Epilepsy Diagnosis & Treatment Revenue Market Share by Company in 2021

    Figure 32. Asia Pacific Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2017-2028)

    Figure 33. Asia Pacific Epilepsy Diagnosis & Treatment Revenue Market Share by Application (2017-2028)

    Figure 34. Asia Pacific Epilepsy Diagnosis & Treatment Revenue Share by Region (2017-2028)

    Figure 35. China Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 36. Japan Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 37. South Korea Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 38. India Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 39. Australia Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 40. Taiwan Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 41. Indonesia Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 42. Thailand Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 43. Malaysia Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 44. Philippines Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 45. Vietnam Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 46. Latin America Epilepsy Diagnosis & Treatment Revenue Market Share by Company in 2021

    Figure 47. Latin America Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2017-2028)

    Figure 48. Latin America Epilepsy Diagnosis & Treatment Revenue Market Share by Application (2017-2028)

    Figure 49. Latin America Epilepsy Diagnosis & Treatment Revenue Share by Country (2017-2028)

    Figure 50. Mexico Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 51. Brazil Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 52. Argentina Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 53. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue Market Share by Company in 2021

    Figure 54. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue Market Share by Type (2017-2028)

    Figure 55. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue Market Share by Application (2017-2028)

    Figure 56. Middle East and Africa Epilepsy Diagnosis & Treatment Revenue Share by Country (2017-2028)

    Figure 57. Turkey Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 58. Saudi Arabia Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 59. U.A.E Epilepsy Diagnosis & Treatment Revenue (2017-2028) & (US$ Million)

    Figure 60. Pfizer Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 61. Johnson & Johnson Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 62. UCB Pharma Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 63. Abbott Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 64. GlaxoSmithKline Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 65. Novartis Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 66. Sanofi Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 67. Takeda Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 68. Medtronic Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 69. Natus Medical Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 70. Siemens Revenue Growth Rate in Epilepsy Diagnosis & Treatment Business (2017-2022)

    Figure 71. Bottom-up and Top-down Approaches for This Report

    Figure 72. Data Triangulation

    Figure 73. Key Executives Interviewed